WallStreetZenWallStreetZen

NASDAQ: FATE
Fate Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for FATE

Based on 9 analysts offering 12 month price targets for Fate Therapeutics Inc.
Min Forecast
$5.00+147.52%
Avg Forecast
$6.27+210.25%
Max Forecast
$10.00+395.05%

Should I buy or sell FATE stock?

Based on 9 analysts offering ratings for Fate Therapeutics Inc.
Buy
Strong Buy
2 analysts 22.22%
Buy
0 analysts 0%
Hold
7 analysts 77.78%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their FATE stock forecasts and price targets.

FATE stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Cantor Fitzgerald
Bottom 11%
11
HoldReiterates$5.00+147.52%2023-09-07
Truist Securities
Bottom 6%
6
HoldReiterates$7.00+246.53%2023-08-16
Morgan Stanley
Top 19%
82
HoldMaintains$5.00+147.52%2023-08-10
Barclays
Bottom 15%
15
Strong BuyMaintains$6.00+197.03%2023-08-10
BMO Capital
Top 8%
93
HoldMaintains$5.40+167.33%2023-08-09
EF Hutton
Bottom 2%
2
Strong BuyReiterates$10.00+395.05%2023-08-09
HC Wainwright & Co.
Bottom 1%
1
HoldReiterates$7.00+246.53%2023-05-05
Stifel Nicolaus
Bottom 7%
7
HoldMaintains$5.00+147.52%2023-05-04
Wells Fargo
Bottom 1%
1
HoldAssumes$6.00+197.03%2023-03-27

1 of 1

Forecast return on equity

Is FATE forecast to generate an efficient return?
Company
N/A
Industry
0.6%
Market
28.78%

Forecast return on assets

Is FATE forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.1%

FATE revenue growth forecast

How is FATE forecast to perform vs Biotechnology companies and vs the US market?
Company
6.74%
Industry
35.17%
Market
8.14%
FATE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
FATE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

FATE vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
FATE$2.02$6.27+210.25%Buy
STRO$3.29$17.50+431.91%Strong Buy
RIGL$1.14$8.50+645.61%Buy
MESO$1.23$6.83+455.53%Hold
IPHA$2.49$11.50+361.85%Buy

Fate Therapeutics Stock Forecast FAQ

Is Fate Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 9 Wall Street analysts covering (NASDAQ: FATE) stock is to Buy FATE stock.

Out of 9 analysts, 2 (22.22%) are recommending FATE as a Strong Buy, 0 (0%) are recommending FATE as a Buy, 7 (77.78%) are recommending FATE as a Hold, 0 (0%) are recommending FATE as a Sell, and 0 (0%) are recommending FATE as a Strong Sell.

If you're new to stock investing, here's how to buy Fate Therapeutics stock.

What is FATE's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: FATE) forecast ROE is N/A, which is considered weak.

What is FATE's Price Target?

According to 9 Wall Street analysts that have issued a 1 year FATE price target, the average FATE price target is $6.27, with the highest FATE stock price forecast at $10.00 and the lowest FATE stock price forecast at $5.00.

On average, Wall Street analysts predict that Fate Therapeutics's share price could reach $6.27 by Sep 7, 2024. The average Fate Therapeutics stock price prediction forecasts a potential upside of 210.25% from the current FATE share price of $2.02.

What is FATE's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: FATE) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.1%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.